VivoSeq
Other

Ozone

0

Pipeline Programs↗

0

Active Trials↗

1

Companies Involved↗

Ozone is an early-stage landscape with 0 programs across 1 company. The most active players are Revotar Biopharmaceuticals AG.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

R

Revotar Biopharmaceuticals AG

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed6 · 86%
Withdrawn1 · 14%

Clinical Trials

Trial Activity

7 trials

The Impact of Ozone Gel on the Bone Height and Density
Completed·SSuez Canal University·N/A·NCT06604819·19 enrolled
Study to Evaluate the Effect of Bimosiamose on Ozone Induced Sputum Neutrophilia
Completed·RRevotar Biopharmaceuticals AG·Phase 2·NCT00962481·18 enrolled
Mechanisms of Ozone-Induced Alterations in Efferocytosis and Phagocytosis
Completed·—·Phase 1·NCT03646877·22 enrolled
ONES Grant: CXCL10/CXCR3 Regulation of Ozone-Induced Epithelial Permeability
Completed·—·Phase 1·NCT03599206·14 enrolled
OZONE_EXO: Comparative Analysis of Protocols for Dental Exactions in Patients at Risk of MRONJ: Case-control Study
Completed·UUniversity of Palermo·Phase 1/2·NCT06072404·117 enrolled
Ozone Therapy in Endodontic Practice, in Vivo Study
Completed·UUniversity of Sao Paulo·Phase 2·NCT00946634·60 enrolled
The Effect of Low Level Ozone Exposure on Healthy Volunteers
Withdrawn·UUniversity of North Carolina, Chapel Hill·Phase 1·NCT00468221

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)